Literature DB >> 23732897

Report from the field: Overview of the Sixth Annual Vaccine Renaissance Conference.

Denice Spero1, Lauren Levitz, Anne S De Groot.   

Abstract

The Sixth Annual Vaccine Renaissance Conference, hosted by the Institute for Immunology and Informatics (iCubed) at the University of Rhode Island (URI), took place on October 15-17, 2012. This conference provides a forum for the review of current progress in the discovery and development of vaccines, and creates an environment for the exchange of ideas. Dr. Joel McCleary opened the conference with a warning about the importance of preparing for well-defined biowarfare threats, including tularemia and Staphylococcal enterotoxin B. Following the keynote address, sessions explored biodefense and preparation for pandemic and biowarfare threats; vaccines for emerging and re-emerging neglected tropical diseases; animal vaccines and human health; and vaccine vectors and the human microbiome. In this issue of Human Vaccines and Immunotherapeutics, seven Vaccine Renaissance Conference speakers will showcase their work; here, we describe a few of the conference highlights.

Entities:  

Keywords:  T cell epitope; animal vaccines; biodefense; emerging infectious diseases; immunoinformatics; immunomodulation; neglected tropical diseases; vaccine design; vaccines

Mesh:

Substances:

Year:  2013        PMID: 23732897      PMCID: PMC3974885          DOI: 10.4161/hv.24833

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  11 in total

1.  Taking the measure of countermeasures: leaders' views on the nation's capacity to develop biodefense countermeasures.

Authors:  Lynne Gilfillan; Bradley T Smith; Thomas V Inglesby; Krishna Kodukula; Ari Schuler; Mark Lister; Tara O'Toole
Journal:  Biosecur Bioterror       Date:  2004

2.  Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease.

Authors:  Debaditya Bhattacharya; Mekki Bensaci; Kathryn E Luker; Gary Luker; Steven Wisdom; Sam R Telford; Linden T Hu
Journal:  Vaccine       Date:  2011-08-02       Impact factor: 3.641

Review 3.  Hyperimmune bovine colostrum for treatment of GI infections: a review and update on Clostridium difficile.

Authors:  Jennifer Steele; Jerlyn Sponseller; Diane Schmidt; Ocean Cohen; Saul Tzipori
Journal:  Hum Vaccin Immunother       Date:  2013-02-22       Impact factor: 3.452

4.  Dengue human infection model: re-establishing a tool for understanding dengue immunology and advancing vaccine development.

Authors:  Stephen J Thomas
Journal:  Hum Vaccin Immunother       Date:  2013-03-06       Impact factor: 3.452

5.  Current biodefense vaccine programs and challenges.

Authors:  Daniel N Wolfe; William Florence; Paula Bryant
Journal:  Hum Vaccin Immunother       Date:  2013-02-21       Impact factor: 3.452

6.  Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses.

Authors:  Derek W Trobaugh; Liyan Yang; Francis A Ennis; Sharone Green
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

Review 7.  Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C.

Authors:  Ayssa A Self; Phyllis T Losikoff; Stephen H Gregory
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

8.  A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.

Authors:  Stephen A Kaba; Clara Brando; Qin Guo; Christian Mittelholzer; Senthilkumar Raman; David Tropel; Ueli Aebi; Peter Burkhard; David E Lanar
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

9.  Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.

Authors:  Stephen A Kaba; Margaret E McCoy; Tais A P F Doll; Clara Brando; Qin Guo; Debleena Dasgupta; Yongkun Yang; Christian Mittelholzer; Roberta Spaccapelo; Andrea Crisanti; Peter Burkhard; David E Lanar
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

Review 10.  Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

Authors:  Anne S De Groot; Leo Einck; Leonard Moise; Michael Chambers; John Ballantyne; Robert W Malone; Matthew Ardito; William Martin
Journal:  Hum Vaccin Immunother       Date:  2013-07-22       Impact factor: 3.452

View more
  1 in total

Review 1.  Immunology of Cryptococcal Infections: Developing a Rational Approach to Patient Therapy.

Authors:  Waleed Elsegeiny; Kieren A Marr; Peter R Williamson
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.